Trial Profile
A real world retrospective,cohort study evaluating effectiveness of use of lenalidamide followed by pomalidamide in relapsed/refractory myeloma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Pomalidomide (Primary)
- Indications Myeloma
- Focus Therapeutic Use
- 21 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association